Chapter 46 :

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch46-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch46-2.gif


is the causative agent of tularemia, an acute and fatal illness in animals and humans. Human infections caused by occur via arthropod bite, handling of infected animals, inhalation of infectious aerosols, and ingestion of contaminated food or water. is highly infectious, with only 10 organisms sufficient to cause illness, and has a notorious reputation for causing laboratory-acquired infections. Within the genus, is joined by 6 lesser-known species which are largely considered environmental species and nonpathogenic or opportunistic pathogens of humans. Whereas causes tularemia in animals and humans, and infect and cause death in fish and abalone, respectively. and are associated with salt or brackish water and are only infrequent causes of opportunistic infections in compromised individuals. was examined by multiple countries for its possible use as both an offensive and retaliatory biological weapon in the years leading up to and following World War II. In 2012, was classified as a Tier 1 agent, one of six bacterial agents considered to present the greatest risk of deliberate misuse with the most significant potential for mass casualties or devastating effects to the economy, critical infrastructure, or public confidence.

Citation: Petersen J, Schriefer M. 2015. , p 851-862. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch46
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

Gram stain of . Magnification, ∼×810. doi:10.1128/9781555817381.ch46.f1

Citation: Petersen J, Schriefer M. 2015. , p 851-862. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

on CA (A) and CHAB (B) after 72 and 48 h of growth, respectively. (Panel A is courtesy of the CDC Public Health Image Library [Larry Stauffer, Oregon State Public Health Laboratory].) doi:10.1128/9781555817381.ch46.f2

Citation: Petersen J, Schriefer M. 2015. , p 851-862. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3

DFA staining of a culture of . Magnification, ∼×490. doi:10.1128/9781555817381.ch46.f3

Citation: Petersen J, Schriefer M. 2015. , p 851-862. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch46
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Sjöstedt A,,. 2005. Francisella, p 200–210. In Brenner DJ,, Krieg NR,, Staley JT,, Garrity GM ( ed), Bergey’s Manual of Systematic Bacteriology, 2nd ed, vol 2. The Proteobacteria. Springer-Verlag, New York, NY.
2. Sjöstedt A. 2007. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 1105: 129.165.
3. Sjödin A,, Svensson K,, Ohrman C,, Ahlinder J,, Lindgren P,, Duodu S,, Johansson A,, Colquhoun DJ,, Larsson P,, Forsman M. 2012. Genome characterisation of the genus Francisella reveals insight into similar evolutionary paths in pathogens of mammals and fish. BMC Genomics 13: 268.
4. Larsson P,, Elfsmark DK,, Svensson K,, Wikström P,, Forsman M,, Brettin T,, Keim P,, Johansson A. 2009. Molecular evolutionary consequences of niche restriction in Francisella tularensis, a facultative intracellular pathogen. PLoS Pathog 5: e1000472.
5. Hollis DG,, Weaver RE,, Steigerwalt AG,, Wenger JD,, Moss CW,, Brenner DJ. 1989. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 27: 16011608.
6. Jensen WI,, Owen CR,, Jellison WL. 1969. Yersinia philomiragia sp. n ., a new member of the Pasteurella group of bacteria, naturally pathogenic for the muskrat ( Ondatra zibethica). J Bacteriol 100: 12371241.
7. Larson CL,, Wicht W,, Jellison WL. 1955. A new organism resembling P. tularensis isolated from water. Public Health Rep 70: 253258.
8. Wenger JD,, Hollis DG,, Weaver RE,, Baker CN,, Brown GR,, Brenner DJ,, Broome CV. 1989. Infection caused by Francisella philomiragia (formerly Yersinia philomiragia): a newly recognized human pathogen. Ann Intern Med 110: 888892.
9. Owen CR,, Buker EO,, Jellison WL,, Lackman DB,, Bell JF. 1964. Comparative studies of Francisella tularensis and Francisella novicida. J Bacteriol 87: 676683.
10. Forsman M,, Sandström G,, Sjöstedt A. 1994. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol 44: 3846.
11. Huber B,, Escudero R,, Busse HJ,, Seibold E,, Scholz HC,, Anda P,, Kämpfer P,, Splettstoesser WD. 2010. Description of Francisella hispaniensis sp. nov., isolated from human blood, reclassification of Francisella novicida (Larson et al. 1955) Olsufiev et al. 1959 as Francisella tularensis subsp. novicida comb. nov. and emended description of the genus Francisella. Int J Syst Evol Microbiol 60: 18871896.
12. Johansson A,, Celli J,, Conlan W,, Elkins KL,, Forsman M,, Keim PS,, Larsson P,, Manoil C,, Nano FE,, Petersen JM,, Sjöstedt A. 2010. Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis. Int J Syst Evol Microbiol 60: 17171718.
13. Escudero R,, Elía M,, Sáez-Nieto JA,, Menéndez V,, Toledo A,, Royo G,, Rodríguez-Vargas M,, Whipp MJ,, Gil H,, Jado I,, Anda P. 2010. A possible novel Francisella genomic species isolated from blood and urine of a patient with severe illness. Clin Microbiol Infect 16: 10261030.
14. Mikalsen J,, Olsen AB,, Tengs T,, Colquhoun DJ. 2007. Francisella philomiragia subsp. noatunensis subsp. nov., isolated from farmed Atlantic cod ( Gadus morhua L.). Int J Syst Evol Microbiol 57: 19601965.
15. Ottem KF,, Nylund A,, Karlsbakk E,, Friis-Møller A,, Kamaishi T. 2009. Elevation of Francisella philomiragia subsp. noatunensis Mikalsen et al. (2007) to Francisella noatunensis comb. nov. [syn. Francisella piscicida Ottem et al. (2008) syn. nov.] and characterization of Francisella noatunensis subsp. orientalis subsp. nov., two important fish pathogens. J Appl Microbiol 106: 12311243.
16. Brevik OJ,, Ottem KF,, Kamaishi T,, Watanabe K,, Nylund A. 2011. Francisella halioticida sp. nov., a pathogen of farmed giant abalone ( Haliotis gigantea) in Japan. J Appl Microbiol 111: 10441056.
17. Qu PH,, Chen SY,, Scholz HC,, Busse HJ,, Gu Q,, Kämpfer P,, Foster JT,, Glaeser SP,, Chen C,, Yang ZC. 2013. Francisella guangzhouensis sp. nov., isolated from air conditioning systems. Int J Syst Evol Microbiol 63: 36283635.
18. Petersen JM,, Carlson J,, Yockey B,, Pillai S,, Kuske C,, Garbalena G,, Pottumarthy S,, Chalcraft L. 2009. Direct isolation of Francisella spp. from environmental samples. Lett Appl Microbiol 48: 663667.
19. Kugeler KJ,, Mead PS,, McGowan KL,, Burnham JM,, Hogarty MD,, Ruchelli E,, Pollard K,, Husband B,, Conley C,, Rivera R,, Kelesidis T,, Lee WM,, Mabey W,, Winchell JM,, Stang HL,, Staples JE,, Chalcraft LJ,, Petersen JM. 2008. Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood. J Clin Microbiol 46: 24282431.
20. Scoles GA. 2004. Phylogenetic analysis of the Francisella-like endosymbionts of Dermacentor ticks. J Med Entomol 41: 277286.
21. Weyant RS,, Moss CW,, Weaver RE,, Hollis DG,, Jordan JG,, Cook EC,, Daneshvar MI. 1996. Identification of Unusual Pathogenic Gram-Negative Aerobic and Facultatively Anaerobic Bacteria, 2nd ed. The Williams & Wilkins Co, Baltimore, MD.
22. Meshcheriakova IS,, Kormilitsyna MI,, Rodionova IV,, Konstantinova ND. 1995. The characteristics of new species of pathogenic microorganisms in the genus Francisella. Zh Mikrobiol Epidemiol Immunobiol 5: 38. (In Russian.)
23. Olsufiev NG,, Emelyanova OS,, Dunaeva TN. 1959. Comparative study of strains of B. tularense in the old and new world and their taxonomy. J Hyg Epidemiol Microbiol Immunol 3: 138149.
24. Mikalsen J,, Olsen AB,, Rudra H,, Moldal T,, Lund H,, Djønne B,, Bergh O,, Colquhoun DJ. 2009. Virulence and pathogenicity of Francisella philomiragia subsp. noatunensis for Atlantic cod, Gadus morhua L., and laboratory mice. J Fish Dis 32: 377381.
25. Olsufjev NG,, Meshcheryakova IS. 1982. Infraspecific taxonomy of tularemia agent Francisella tularensis McCoy et Chapin. J Hyg Epidemiol Microbiol Immunol 3: 291299.
26. Molins CR,, Petersen JM. 2010. Subpopulations of F. tularensis subspecies tularensis and holarctica: identification and associated epidemiology. Future Microbiol 5: 649661.
27. Kugeler KJ,, Mead PS,, Janusz AM,, Staples JE,, Kubota KA,, Chalcraft LG,, Petersen JM. 2009. Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis 48: 863870.
28. Dennis DT,, Inglesby TV,, Henderson DA,, Bartlett JG,, Ascher MS,, Eitzen E,, Fine AD,, Friedlander AM,, Hauer J,, Layton M,, Lillibridge SR,, McDade JE,, Osterholm MT,, O’Toole T,, Parker G,, Perl TM,, Russell PK,, Tonat K,, Working Group on Civilian Biodefense. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285: 27632773.
29. Anda P,, del Pozo JS,, Garcia JMD,, Escudero R,, Peña FJG,, Velasco MCL,, Sellek RE,, Chillarón MRJ,, Serrano LPS,, Navarro JFM. 2001. Waterborne outbreak of tularemia associated with crayfish fishing. Emerg Infect Dis 7: 575582.
30. Martín CM,, Gallardo T,, Mateos L,, Vián E,, García MJ,, Ramos J,, Berjón AC,, del Carmen Viña M,, García MP,, Yáñez J,, González LC,, Muñoz T,, Allue M,, Andrés C,, Ruiz C,, Castrodeza J. 2007. Outbreak of tularaemia in Castilla y León, Spain. Euro Surveill 12: E071108.1.
31. Akalin H,, Helvaci S,, Gedikogˇlu S. 2009. Re-emergence of tularemia in Turkey. Int J Infect Dis 13: 547551.
32. Larssen KW,, Afset JE,, Heier BT,, Krogh T,, Handeland K,, Vikøren T,, Bergh K. 2011. Outbreak of tularaemia in central Norway, January to March 2011. Euro Surveill 16( 13): pii=19828.
33. Payne L,, Arneborn M,, Tegnell A,, Giesecke J. 2005. Endemic tularemia, Sweden, 2003. Emerg Infect Dis 11: 14401442.
34. Centers for Disease Control and Prevention. 2002. Tularemia—United States, 1990–2000. MMWR Morb Mortal Wkly Rep 51: 182184.
35. Feldman KA,, Enscore R,, Lathrop S,, Matyas B,, McGuill M,, Schriefer M,, Stiles-Enos D,, Dennis D,, Hayes E. 2001. Outbreak of primary pneumonic tularemia on Martha’s Vineyard. N Engl J Med 345: 16011606.
36. Matyas BT,, Nieder HS,, Telford SR III. 2007. Pneumonic tularemia on Martha’s Vineyard: clinical, epidemiologic, and ecological characteristics. Ann N Y Acad Sci 1105: 351377.
37. Petersen JM,, Carlson JK,, Dietrich G,, Eisen RJ,, Coombs J,, Janusz AM,, Summers J,, Beard CB,, Mead PS. 2008. Multiple Francisella tularensis subspecies and clades, tularemia outbreak, Utah. Emerg Infect Dis 14: 19281930.
38. Staples JE,, Kubota KA,, Chalcraft LG,, Mead PS,, Petersen JM. 2006. Epidemiologic and molecular analysis of human tularemia, United States, 1964–2004. Emerg Infect Dis 12: 11131118.
39. Bell JF,. 1980. Tularemia, p 161193. In Steele JH ( ed), CRC Handbook Series in Zoonoses. CRC Press, Boca Raton, FL.
40. Hopla CE,,, Hopla AK,. 1994. Tularemia, p 113126. In Beran GW,, Steele JH ( ed), Handbook of Zoonoses, 2nd ed. CRC Press, Boca Raton, FL.
41. Jellison WL,, Owen CR,, Bell JF,, Kohls GM. 1961. Tularemia and animal populations: ecology and epi-zootiology. Wildl Dis 17: 115.
42. Brett M,, Doppalapudi A,, Respicio-Kingry LB,, Myers D,, Husband B,, Pollard K,, Mead P,, Petersen JM,, Whitener CJ. 2012. Francisella novicida bacteremia after a near-drowning accident. J Clin Microbiol 50: 28262829.
43. Leelaporn A,, Yongyod S,, Limsrivanichakorn S,, Yungyuen T,, Kiratisin P. 2008. Francisella novicida bacteremia, Thailand. Emerg Infect Dis 14: 19351937.
44. Whipp MJ,, Davis JM,, Lum G,, de Boer J,, Zhou Y,, Bearden SW,, Petersen JM,, Chu MC,, Hogg G. 2003. Characterization of a novicida-like subspecies of Francisella tularensis in Australia. J Med Microbiol 52: 839842.
45. Friis-Møller A,, Lemming LE,, Valerius NH,, Bruun B. 2004. Problems in identification of Francisella philomiragia associated with fatal bacteremia in a patient with chronic granulomatous disease. J Clin Microbiol 42: 18401842.
46. Sicherer SH,, Asturias EJ,, Winkelstein JA,, Dick JD,, Willoughby RE. 1997. Francisella philomiragia sepsis in chronic granulomatous disease. Pediatr Infect Dis J 16: 420422.
47. World Health Organization. 2007. WHO Guidelines on Tularemia. World Health Organization, Geneva, Switzerland. http://www.cdc.gov/tularemia/resources/whotulare miamanual.pdf.
48. Evans ME,, Gregory DW,, Schaffner W,, McGee ZA. 1985. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 64: 251269.
49. Molins CR,, Delorey M,, Yockey BM,, Young JW,, Sheldon SW,, Reese SM,, Schriefer ME,, Petersen JM. 2010. Virulence comparison among Francisella tularensis subsp. tularensis clades in mice. PLoS One 5( 4): e10205.
50. Birdsell DN,, Stewart T,, Vogler AJ,, Lawaczeck E,, Diggs A,, Sylvester TL,, Buchhagen JL,, Auerbach RK,, Keim P,, Wagner DM. 2009. Francisella tularensis subsp. novicida isolated from a human in Arizona. BMC Res Notes 2: 223.
51. Clarridge JE III,, Raich TJ,, Sjöstedt A,, Sandström G,, Darouiche RO,, Shawar RM,, Georghiou PR,, Osting C,, Vo L. 1996. Characterization of two unusual clinically significant Francisella strains. J Clin Microbiol 34: 19952000.
52. Birkbeck TH,, Feist SW,, Verner-Jeffreys DW. 2011. Francisella infections in fish and shellfish. J Fish Dis 34: 173187.
53. Overholt EI,, Tigertt WD,, Kadull PJ,, Ward MK,, Charkes ND,, Rene RM,, Salzman TE,, Stephens M. 1961. An analysis of forty-two cases of laboratory-acquired tularemia. Am J Med 30: 785806.
54. Pike RM. 1976. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 13: 105114.
55. Shapiro DS,, Schwartz DR. 2002. Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure. J Clin Microbiol 40: 22782281.
56. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Institutes of Health. 2007. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, Washington, DC. http://www.cdc.gov/od/ohs/biosfty/bmbl5/bmbl5toc.htm.
57. Johansson A,, Berglund L,, Eriksson U,, Göransson I,, Wollin R,, Forsman M,, Tärnvik A,, Sjöstedt A. 2000. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 38: 2226.
58. Guarner J,, Breer PR,, Bartlett JC,, Chu MC,, Shieh WJ,, Zaki SR. 1999. Immunohistochemical detection of Francisella tularensis in formalin-fixed paraffin-embedded tissue. Appl Immunohistochem Mol Morphol 7: 122126.
59. Sjöstedt A,, Eriksson U,, Berglund L,, Tärnvik A. 1997. Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol 35: 10451048.
60. Celebi G,, Baruönü F,, Ayogˇlu F,, Cinar F,, Karadenizli A,, Ugˇur MB,, Gedikogˇlu S. 2006. Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn J Infect Dis 59: 229234.
61. Versage JL,, Severin DD,, Chu MC,, Petersen JM. 2003. Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens. J Clin Microbiol 41: 54925499.
62. Willke A,, Meric M,, Grunow R,, Sayan M,, Finke EJ,, Splettstösser W,, Seibold E,, Erdogan S,, Ergonul O,, Yumuk Z,, Gedikoglu S. 2009. An outbreak of oropharyngeal tularaemia linked to natural spring water. J Med Microbiol 58: 112116.
63. Maurin M,, Pelloux I,, Brion JP,, Del Banõ JN,, Picard A. 2011. Human tularemia in France, 2006–2010. Clin Infect Dis 53: 133141.
64. Ahlinder J,, Öhrman C,, Svensson K,, Lindgren P,, Johansson A,, Forsman M,, Larsson P,, Sjödin A. 2012. Increased knowledge of Francisella genus diversity highlights the benefits of optimised DNA-based assays. BMC Microbiol 12: 220.
65. Kugeler KJ,, Gurfield N,, Creek JG,, Mahoney KS,, Versage JL,, Petersen JM. 2005. Discrimination between Francisella tularensis and Francisella-like endosymbionts when screening ticks by PCR. Appl Environ Microbiol 71: 75947597.
66. Sréter-Lancz Z,, Széll Z,, Sréter T,, Márialigeti K. 2008. Detection of a novel Francisella in Dermacentor reticulatus: a need for careful evaluation of PCR-based identification of Francisella tularensis in Eurasian ticks. Vector Borne Zoonotic Dis 9: 123126.
67. Barns SM,, Grow CC,, Okinaka RT,, Keim P,, Kuske CR. 2005. Detection of diverse new Francisella-like bacteria in environmental samples. Appl Environ Microbiol 71: 54945500.
68. Petersen JM,, Schriefer ME,, Gage KL,, Montenieri JA,, Carter LG,, Stanley M,, Chu MC. 2004. Methods for enhanced culture recovery of Francisella tularensis. Appl Environ Microbiol 70: 37333735.
69. Thomas RM,, Titball RW,, Oyston PC,, Griffin K,, Waters E,, Hitchen PG,, Michell SL,, Grice ID,, Wilson JC,, Prior JL. 2007. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun 75: 371378.
70. Forsman M,, Sandström G,, Jaurin B. 1990. Identification of Francisella species and discrimination of type A and type B strains of F. tularensis by 16S rRNA analysis. Appl Environ Microbiol 56: 949955.
71. Jantzen E,, Berdal BP,, Omland T. 1979. Cellular fatty acid composition of Francisella tularensis. J Clin Microbiol 10: 928930.
72. Seibold E,, Maier T,, Kostrzewa M,, Zeman E,, Splettstoesser W. 2010. Identification of Francisella tularensis by whole-cell matrix-assisted laser desorption ionization–time of flight mass spectrometry: fast, reliable, robust, and cost-effective differentiation on species and subspecies levels. J Clin Microbiol 48: 10611069.
73. Sandström G,, Sjöstedt A,, Forsman M,, Pavlovich NV,, Mishankin BN. 1992. Characterization and classification of strains of Francisella tularensis isolated in the Central Asian focus of the Soviet Union, and in Japan. J Clin Microbiol 30: 172175.
74. Molins CR,, Carlson JK,, Coombs J,, Petersen JM. 2009. Identification of Francisella tularensis subsp. tularensis A1 and A2 infections by real-time polymerase chain reaction. Diagn Microbiol Infect Dis 64: 612.
75. Johansson A,, Farlow J,, Larsson P,, Dukerich M,, Chambers E,, Byström M,, Fox J,, Chu M,, Forsman M,, Sjöstedt A,, Keim P. 2004. Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis. J Bacteriol 186: 58085818.
76. Vogler AJ,, Birdsell D,, Wagner DM,, Keim P. 2009. An optimized, multiplexed multi-locus variable-number tandem repeat analysis system for genotyping Francisella tularensis. Lett Appl Microbiol 48: 140144.
77. Tärnvik A. 1989. Nature of protective immunity to Francisella tularensis. Rev Infect Dis 11: 440451.
78. Viljanen MK,, Nurmi T,, Salminen A. 1983. Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen. J Infect Dis 148: 715720.
79. Bevanger L,, Maeland JA,, Kvam AI. 1994. Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later. Clin Diagn Lab Immunol 1: 238240.
80. Waag DM,, McKee KT Jr,, Sandström G,, Pratt LLK,, Bolt CR,, England MJ,, Nelson GO,, Williams JC. 1995. Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis. Clin Diagn Lab Immunol 2: 143148.
81. Brown SL,, McKinney FT,, Klein GC,, Jones WL. 1980. Evaluation of a safranin-O-stained antigen microagglutination test for Francisella tularensis antibodies. J Clin Microbiol 11: 146148.
82. Behan KA,, Kleinn GC. 1982. Reduction of Brucella species and Francisella tularensis cross-reacting agglutinins by dithiothreitol. J Clin Microbiol 16: 756757.
83. Ohara S,, Sato T,, Homma M. 1974. Serological studies on Francisella tularensis, Francisella novicida, Yersinia philomiragia, and Brucella abortus. Int J Syst Bacteriol 24: 191196.
84. Porsch-Özcürümez M,, Kischel N,, Priebe H,, Splettstösser W,, Finke EJ,, Grunow R. 2004. Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immuno-fluorescence assay, and flow cytometric serological diagnosis of tularemia. Clin Diagn Lab Immunol 11: 10081015.
85. Schmitt P,, Splettstosser W,, Porsch-Özcürümez M,, Finke EJ,, Grunow R. 2005. A novel screening ELISA and a confirmatory Western blot useful for diagnosis and epidemiological studies of tularemia. Epidemiol Infect 133: 759766.
86. Ericsson M,, Sandström G,, Sjöstedt A,, Tärnvik A. 1994. Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis. J Infect Dis 170: 110114.
87. Surcel HM,, Ilonen J,, Poikonen K,, Herva E. 1989. Francisella tularensis-specific T-cell clones are human leukocyte antigen class II restricted, secrete interleukin-2 and gamma interferon, and induce immunoglobulin production. Infect Immun 57: 29062908.
88. Surcel HM,, Sarvas M,, Helander IM,, Herva E. 1989. Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. Microb Pathog 7: 411419.
89. Eliasson H,, Olcén P,, Sjöstedt A,, Jurstrand M,, Bäck E,, Andersson S. 2008. Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test. Clin Vaccine Immunol 15: 12381243.
90. Tärnvik A,, Chu MC. 2007. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci 1105: 378404.
91. Urich SK,, Petersen JM. 2008. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob Agents Chemother 52: 22762278.
92. Georgi E,, Schacht E,, Scholz HC,, Splettstoesser WD. 2012. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species. J Antimicrob Chemother 67: 24292433.
93. Kaya A,, Uysal ,, Güven AS,, Engin A,, Gültürk A,, I˙çagˇasıogˇlu FD,, Cevit Ö. 2011. Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia. Med Sci Monit 17: CR376CR380.
94. Meric M,, Willke A,, Finke EJ,, Grunow R,, Sayan M,, Erdogan S,, Gedikoglu S. 2008. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS 116: 6673.
95. Antunes NT,, Frase H,, Toth M,, Vakulenko SB. 2012. The class A β-lactamase FTU-1 is native to Francisella tularensis. Antimicrob Agents Chemother 56: 666671.
96. Cross JT,, Jacobs RF. 1993. Tularemia: treatment failures with outpatient use of ceftriaxone. Clin Infect Dis 17: 976980.
97. Kudelina R I,, Olsufiev NG. 1980. Sensitivity to macrolide antibiotics and lincomycin in Francisella tularensis holarctica. J Hyg Epidemiol Microbiol Immunol 24: 8491.
98. Clinical and Laboratory Standards Institute. 2006. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. CLSI Document M7-A7. Approved Standard, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
99. Clinical and Laboratory Standards Institute. 2009. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
100. Federal Register. 2012. Possession, use, and transfer of select agents and toxins; biennial review; final rule. 42 CFR Part 73. Fed Regist 77: 6108361115.


Generic image for table

Differentiation of from similar Gram-negative genera

Citation: Petersen J, Schriefer M. 2015. , p 851-862. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch46
Generic image for table

Citation: Petersen J, Schriefer M. 2015. , p 851-862. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch46
Generic image for table

Epidemiology of spp. affecting humans

Citation: Petersen J, Schriefer M. 2015. , p 851-862. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch46

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error